Stated-preference study to examine the economic value of benefits of avoiding selected adverse human health outcomes due to exposure to chemicals in the European Union: Part III: Carcinogens

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11690%2F14%3A10294057" target="_blank" >RIV/00216208:11690/14:10294057 - isvavai.cz</a>

Výsledek na webu

<a href="http://echa.europa.eu/documents/10162/13630/study_economic_benefits_avoiding_adverse_health_outcomes_3_en.pdf" target="_blank" >http://echa.europa.eu/documents/10162/13630/study_economic_benefits_avoiding_adverse_health_outcomes_3_en.pdf</a>

DOI - Digital Object Identifier

—

Jazyk výsledku

angličtina

Název v původním jazyce

Stated-preference study to examine the economic value of benefits of avoiding selected adverse human health outcomes due to exposure to chemicals in the European Union: Part III: Carcinogens

Popis výsledku v původním jazyce

Stated-preference study to examine the economic value of benefits of avoiding selected adverse human health outcomes due to exposure to chemicals in the European Union: Part III: Carcinogens The primary objective of this stated-preference study was to estimate willingness to pay to avoid selected adverse human health outcomes due to exposure to chemicals in the European Union and to derive representative EU-wide benefit estimates reference values. The results are intended for use by ECHA and other bodies when carrying out socio-economic analyses or health impact assessments in connection to REACH Regulation. This report focuses on health outcomes linked to carcinogens, particularly to cancer risks. Each health outcome that is valued in this study was selected based on a comprehensive literature review, consultations with epidemiologists and medical experts and in close cooperation with ECHA.

Název v anglickém jazyce

Stated-preference study to examine the economic value of benefits of avoiding selected adverse human health outcomes due to exposure to chemicals in the European Union: Part III: Carcinogens

Popis výsledku anglicky

Stated-preference study to examine the economic value of benefits of avoiding selected adverse human health outcomes due to exposure to chemicals in the European Union: Part III: Carcinogens The primary objective of this stated-preference study was to estimate willingness to pay to avoid selected adverse human health outcomes due to exposure to chemicals in the European Union and to derive representative EU-wide benefit estimates reference values. The results are intended for use by ECHA and other bodies when carrying out socio-economic analyses or health impact assessments in connection to REACH Regulation. This report focuses on health outcomes linked to carcinogens, particularly to cancer risks. Each health outcome that is valued in this study was selected based on a comprehensive literature review, consultations with epidemiologists and medical experts and in close cooperation with ECHA.

Druh

V_souhrn - Souhrnná výzkumná zpráva

CEP obor

AH - Ekonomie

OECD FORD obor

—

Projekt

—

Návaznosti

N - Vyzkumna aktivita podporovana z neverejnych zdroju

Rok uplatnění

2014

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Počet stran výsledku

124

Místo vydání

—

Název nakladatele resp. objednatele

European Chemicals Agency

Verze

—